SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
YI

111, Inc. (NASDAQ:YI)

CN · Delayed Price · Currency is USD
Healthcare · Medical - Distribution
$2.36-$0.15 (-5.98%)
 
Market cap
$20.7M
Insider Score
Health Score
Listed since
Sep 12, 2018
Website
Market Cap$20.73M-29.3%
Revenue (ttm)$10.44B-26.4%
Net Income-$95.03M-28.2%
EPS-$11.92-39.3%
Shares Out8.79M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,467
Open$2.39
Previous Close$2.51
Day's Range$2.33 - $2.39
52-Week Range$2.33 - $11.17
Beta0.67
Analystsn/a
Price Targetn/a
Earnings DateDec 10, 2026
-7.97% (1D)
No price history available.

About YI

Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.

Address
No.295 ZuChongZhi Road, Shanghai, SH, 201203, CN
Market Cap
21 million
Employees
1,063
Industrial Classification
Medical - Distribution

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$328.45K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Sound
From YI’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-5.98%
5 Days
-17.19%
1 Month
-23.13%
6 Months
-58.60%
1 Year
-29.34%

$YI stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in YI holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by YI's directors and management

Net Shares Purchased by Insiders−2M−1M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

YI Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New YI patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to YI from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from YI’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
28
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Sep 24
0255075100Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 43.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 24Sep 29Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.